TY - JOUR AU - Arienti, Chiara AU - Tesei, Anna AU - Verdecchia, Giorgio Maria AU - Framarini, Massimo AU - Virzì, Salvatore AU - Grassi, Antonio AU - Scarpi, Emanuela AU - Turci, Livia AU - Silvestrini, Rosella AU - Amadori, Dino AU - Zoli, Wainer PY - 2011 DA - 2011/06/20 TI - Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy JO - Journal of Translational Medicine SP - 94 VL - 9 IS - 1 AB - Platinum-based regimens are the treatments of choice in ovarian cancer, which remains the leading cause of death from gynecological malignancies in the Western world. The aim of the present study was to compare the advantages and limits of a conventional chemosensitivity test with those of new biomolecular markers in predicting response to platinum regimens in a series of patients with peritoneal carcinomatosis from ovarian cancer. SN - 1479-5876 UR - https://doi.org/10.1186/1479-5876-9-94 DO - 10.1186/1479-5876-9-94 ID - Arienti2011 ER -